Mary T. Szela, CEO AND PRESIDENT at TriSalus Life Sciences, Inc. (TLSI), bought 10,040 shares at $5.28 ($52K) on 2025-01-30, disclosed to the SEC on 2025-01-31.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.03 | 5,030 | $25K | 48.9% |
| 2 | $5.28 | 5,010 | $26K | 51.1% |
| Total | $5.15 avg | 10,040 | $52K | 100% |
| Filing → |
| TLSI | SELL | 2026-03-20 | $79K | — | Filing → |
| TLSI | BUY | 2026-02-23 | $125K | — | Filing → |
| TLSI | BUY | 2025-01-29 | $50K | — | Filing → |